The Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG) have published a new guideline around faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC).
1 The guideline was written by a multidisciplinary team including GPs and patient representatives, and includes recommendations for both primary and secondary care. NHS England has subsequently written to all GP practices in England recommending they implement this guideline ‘in full’,
2 but this has created concern among some GPs regarding a perceived shifting of risk and responsibility to primary care. This article reviews the recommendations made by the ACPGBI/BSG and considers what they mean for primary care clinicians.